<VariationArchive RecordType="classified" VariationID="1805436" VariationName="NM_001372066.1(TFAP2A):c.481del (p.Val161fs)" VariationType="Deletion" Accession="VCV001805436" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-12-24" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1862448" VariationID="1805436">
      <GeneList>
        <Gene Symbol="TFAP2A" FullName="transcription factor AP-2 alpha" GeneID="7020" HGNC_ID="HGNC:11742" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6p24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="10396677" stop="10419659" display_start="10396677" display_stop="10419659" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="10396915" stop="10419796" display_start="10396915" display_stop="10419796" Strand="-" />
          </Location>
          <OMIM>107580</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001372066.1(TFAP2A):c.481del (p.Val161fs)</Name>
      <CanonicalSPDI>NC_000006.12:10409905:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6p24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="10409906" stop="10409906" display_start="10409906" display_stop="10409906" variantLength="1" positionVCF="10409905" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="10410139" stop="10410139" display_start="10410139" display_stop="10410139" variantLength="1" positionVCF="10410138" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>V153fs</ProteinChange>
      <ProteinChange>V155fs</ProteinChange>
      <ProteinChange>V161fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.10410140del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.10410140del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.10409907del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.10409907del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016151.1" sequenceAccession="NG_016151" sequenceVersion="1" change="g.14659del">
            <Expression>NG_016151.1:g.14659del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001032280.3" sequenceAccession="NM_001032280" sequenceVersion="3" change="c.457del">
            <Expression>NM_001032280.3:c.457del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001027451.1" sequenceAccession="NP_001027451" sequenceVersion="1" change="p.Val153fs">
            <Expression>NP_001027451.1:p.Val153fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042425.3" sequenceAccession="NM_001042425" sequenceVersion="3" change="c.463del">
            <Expression>NM_001042425.3:c.463del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001035890.1" sequenceAccession="NP_001035890" sequenceVersion="1" change="p.Val155fs">
            <Expression>NP_001035890.1:p.Val155fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001372066.1" sequenceAccession="NM_001372066" sequenceVersion="1" change="c.481del" MANESelect="true">
            <Expression>NM_001372066.1:c.481del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001358995.1" sequenceAccession="NP_001358995" sequenceVersion="1" change="p.Val161fs">
            <Expression>NP_001358995.1:p.Val161fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001372066.1(TFAP2A):c.481del (p.Val161fs) AND Branchiooculofacial syndrome" Accession="RCV002471854" Version="1">
        <ClassifiedConditionList TraitSetID="5973">
          <ClassifiedCondition DB="MedGen" ID="C0376524">Branchiooculofacial syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-06-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-06-11" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21204207</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21539471</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21728810</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23578821</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5973" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4707" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Branchiooculofacial syndrome</ElementValue>
                <XRef ID="Branchiooculofacial+Syndrome/954" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007235" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BOFS syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Branchial clefts with characteristic facies growth retardation imperforate nasolacrimal duct and premature aging</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hemangiomatous branchial clefts-lip pseudocleft syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lip pseudocleft-hemangiomatous branchial cyst syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Branchio-Oculo-Facial Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BOF SYNDROME</ElementValue>
                <XRef Type="MIM" ID="113620" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BOFS</ElementValue>
                <XRef Type="MIM" ID="113620" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The branchiooculofacial syndrome (BOFS) is characterized by: branchial (cervical or infra- or supra-auricular) skin defects that range from barely perceptible thin skin or hair patch to erythematous "hemangiomatous" lesions to large weeping erosions; ocular anomalies that can include microphthalmia, anophthalmia, coloboma, and nasolacrimal duct stenosis/atresia; and facial anomalies that can include ocular hypertelorism or telecanthus, broad nasal tip, upslanted palpebral fissures, cleft lip or prominent philtral pillars that give the appearance of a repaired cleft lip (formerly called "pseudocleft lip") with or without cleft palate, upper lip pits, and lower facial weakness (asymmetric crying face or partial 7th cranial nerve weakness). Malformed and prominent pinnae and hearing loss from inner ear and/or petrous bone anomalies are common. Intellect is usually normal.</Attribute>
                <XRef ID="NBK55063" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3212" />
                <XRef ID="3212" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21634087</ID>
                <ID Source="BookShelf">NBK55063</ID>
              </Citation>
              <XRef ID="1297" DB="Orphanet" />
              <XRef ID="C0376524" DB="MedGen" />
              <XRef ID="D019280" DB="MeSH" />
              <XRef ID="MONDO:0007235" DB="MONDO" />
              <XRef Type="MIM" ID="113620" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5413753" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_001032280_2_TFAP2A_c_457delG" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002766848" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-06-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21204207</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21539471</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21728810</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23578821</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.2, this variant is classified as Pathogenic. Following criteria are met: 0103 - Dominant negative and loss of function are known mechanisms of disease in this gene and are associated with Branchiooculofacial syndrome. NMD predicted variants are associated with loss of function mechanism, whereas missense mutations within DNA-binding domain are linked to dominant negative mechanism (PMID: 23578821). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction) (exon2 of 7). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0702 - Other NMD predicted variants comparable to the one identified in this case have strong previous evidence for pathogenicity. Many NMD predicted variants have been reported as pathogenic in individuals with this Branchiooculofacial syndrome (ClinVar, PMID: 21204207, 21728810, 21539471). (SP) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1203 - This variant has been shown to be de novo in the proband (parental status confirmed by trio analysis). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TFAP2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_2455</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001032280.2:c.457delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="113620" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5413753" TraitType="Disease" MappingType="XRef" MappingValue="113620" MappingRef="OMIM">
        <MedGen CUI="C0376524" Name="Branchiooculofacial syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

